262 related articles for article (PubMed ID: 11745430)
1. Active immunization against cancer with dendritic cells: the near future.
Steinman RM; Dhodapkar M
Int J Cancer; 2001 Nov; 94(4):459-73. PubMed ID: 11745430
[No Abstract] [Full Text] [Related]
2. Dendritic cell-based vaccines and therapies for cancer.
Tatsumi T; Storkus WJ
Expert Opin Biol Ther; 2002 Dec; 2(8):919-28. PubMed ID: 12517270
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy and Vaccine Development.
Leung C; Münz C; Riemer A
J Immunol Res; 2018; 2018():8751027. PubMed ID: 30009188
[No Abstract] [Full Text] [Related]
4. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
H Yi D; Appel S
Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells in tumor immunology and immunotherapy.
Turtle CJ; Hart DN
Curr Drug Targets; 2004 Jan; 5(1):17-39. PubMed ID: 14738216
[TBL] [Abstract][Full Text] [Related]
6. Cancer vaccines.
Chekhun VF
Exp Oncol; 2008 Jun; 30(2):90. PubMed ID: 18680872
[No Abstract] [Full Text] [Related]
7. Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
Shurin MR; Gregory M; Morris JC; Malyguine AM
Expert Opin Biol Ther; 2010 Nov; 10(11):1539-53. PubMed ID: 20955111
[TBL] [Abstract][Full Text] [Related]
8. Dendritic Cell-Based Immunotherapy: State of the Art and Beyond.
Bol KF; Schreibelt G; Gerritsen WR; de Vries IJ; Figdor CG
Clin Cancer Res; 2016 Apr; 22(8):1897-906. PubMed ID: 27084743
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell-based immunization for cancer therapy.
Morse MA; Lyerly HK
Adv Exp Med Biol; 2000; 465():335-46. PubMed ID: 10810637
[No Abstract] [Full Text] [Related]
10. Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy.
Fassnacht M; Lee J; Milazzo C; Boczkowski D; Su Z; Nair S; Gilboa E
Clin Cancer Res; 2005 Aug; 11(15):5566-71. PubMed ID: 16061874
[TBL] [Abstract][Full Text] [Related]
11. The role of molecular imaging in the development of dendritic cell-based cancer vaccines.
Lucignani G; Rescigno M
Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):725-30. PubMed ID: 15995874
[No Abstract] [Full Text] [Related]
12. Dendritic cells: a journey from laboratory to clinic.
Cerundolo V; Hermans IF; Salio M
Nat Immunol; 2004 Jan; 5(1):7-10. PubMed ID: 14699398
[No Abstract] [Full Text] [Related]
13. Current status and future applications of cellular therapies for cancer.
Copier J; Bodman-Smith M; Dalgleish A
Immunotherapy; 2011 Apr; 3(4):507-16. PubMed ID: 21463192
[TBL] [Abstract][Full Text] [Related]
14. IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination.
Llopiz D; Ruiz M; Infante S; Villanueva L; Silva L; Hervas-Stubbs S; Alignani D; Guruceaga E; Lasarte JJ; Sarobe P
Oncotarget; 2017 Jan; 8(2):2659-2671. PubMed ID: 27926522
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells as natural adjuvants and modulators of immune response in cancer immunotherapy.
Alli RS; Khar A
Indian J Biochem Biophys; 2002 Dec; 39(6):363-7. PubMed ID: 22905392
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cell vaccination and other strategies to tip the balance of the immune system : DC2007 5th International Meeting, July 16-18, Bamberg, Germany.
Schaft N; Birkholz K; Hofmann C; Schmid M; Theiner G; Dörrie J
Cancer Immunol Immunother; 2008 Jun; 57(6):913-28. PubMed ID: 18236041
[No Abstract] [Full Text] [Related]
17. Dendritic cell-based immunotherapy for cancer and relevant challenges for transfusion medicine.
Voss CY; Albertini MR; Malter JS
Transfus Med Rev; 2004 Jul; 18(3):189-202. PubMed ID: 15248169
[TBL] [Abstract][Full Text] [Related]
18. Cancer Immunotherapy: Theory and Application.
Chen G; Bodogai M; Tamehiro N; Shen C; Dou J
J Immunol Res; 2018; 2018():7502161. PubMed ID: 30035133
[No Abstract] [Full Text] [Related]
19. Dendritic cell immunotherapy for the treatment of neoplastic disease.
Decker WK; Xing D; Shpall EJ
Biol Blood Marrow Transplant; 2006 Feb; 12(2):113-25. PubMed ID: 16443510
[TBL] [Abstract][Full Text] [Related]
20. Part I: Vaccines for solid tumours.
Mocellin S; Mandruzzato S; Bronte V; Lise M; Nitti D
Lancet Oncol; 2004 Nov; 5(11):681-9. PubMed ID: 15522656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
